Publications Archive
Uppsala Reports
ADR Newsletter
- Adverse Reaction Newsletter 1999:4 (Adobe Acrobat document, 50 Kb)
- Adverse Reaction Newsletter 1999:3 (Adobe Acrobat document, 56 Kb)
- Adverse Reaction Newsletter 1999:2 (Adobe Acrobat document, 44 Kb)
- Adverse Reaction Newsletter 1999:1 (Adobe Acrobat document, 44 Kb)
- Adverse Reaction Newsletter 1998:4 (Adobe Acrobat document, 87 Kb)
- Adverse Reaction Newsletter 1998:3 (Adobe Acrobat document, 63 Kb)
- Adverse Reaction Newsletter 1998:2 (Adobe Acrobat document, 66 Kb)
- Adverse Reaction Newsletter 1998:1 (Adobe Acrobat document, 55 Kb)
- Adverse Reaction Newsletter 1997:4 (web page)
- Adverse Reaction Newsletter 1997:3 (web page)
- Adverse Reaction Newsletter 1997:2 (Adobe Acrobat document, 400 Kb)
- Adverse Reaction Newsletter 1997:1 (web page)
- Adverse Reaction Newsletter 1996:4 (web page)
- Adverse Reaction Newsletter 1996:3 (web page)
- Adverse Reaction Newsletter 1996:2 (Adobe Acrobat document, 130 Kb)
- Adverse Reaction Newsletter 1996:1 (Adobe Acrobat document, 910 Kb)
[Top of page]
UMC responds to European Commission Public Consultation
The 11-page detailed response from the Uppsala Monitoring Centre to the report 'Assessment of the European Community System of Pharmacovigilance' prepared by the Fraunhofer Institute Systems and Innovation Research and dated 25 January 2006 is available here for download.
UMC response to European Commission 2006
The Erice Manifesto (2007)
The Erice Manifesto (Adobe Acrobat 85 Kb)
[Top of page]
Abacavir - Myocardial Infarction
The following pdf document was made available in conjunction with an article in the Lancet in 2008.
Abacavir - myocardial infarction (20Kb Adobe Acrobat pdf file)
Publications Archive last updated 29 October 2009